SAN DIEGO--(BUSINESS WIRE)--Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that Dr. Mark Erion, president, chief executive officer and chief scientific officer, will present at the 11th Annual BIO CEO & Investor Conference at the Waldorf-Astoria in New York City. Dr. Erion is scheduled to present on Monday, February 9 at 2:15pm Eastern Time and is expected to provide an overview of the Company and its product candidates. The Company’s presentation will be webcast.
